Thrombopoietin Receptor Agonist
2 clinical trials · Condition
◉ Watch Thrombopoietin Receptor Agonist
| Record | Firm | Date |
|---|---|---|
| Safety of Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP (NCT05846529) | Assiut University | 2023-06-01 |
| Eltrombopag and Romiplostim Used Alternatively in Patients With Immune Thrombopenia (ITP): Efficacy and Safety. (NCT01618734) | Henri Mondor University Hospital | 2012-01-01 |
Track Thrombopoietin Receptor Agonist automatically
Every clearance here is in the API, with alerts when new ones post.